CS235079B2 - Method of antitumour substance preparation - Google Patents

Method of antitumour substance preparation Download PDF

Info

Publication number
CS235079B2
CS235079B2 CS794488A CS448879A CS235079B2 CS 235079 B2 CS235079 B2 CS 235079B2 CS 794488 A CS794488 A CS 794488A CS 448879 A CS448879 A CS 448879A CS 235079 B2 CS235079 B2 CS 235079B2
Authority
CS
Czechoslovakia
Prior art keywords
cells
concentration
treated
hours
preparation
Prior art date
Application number
CS794488A
Other languages
Czech (cs)
English (en)
Inventor
Yutaka Sugawara
Akihiro Yamamoto
Mitsuaki Handa
Hiroko Usami
Haruki Ogawa
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of CS235079B2 publication Critical patent/CS235079B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CS794488A 1978-06-29 1979-06-28 Method of antitumour substance preparation CS235079B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7803978A JPS557014A (en) 1978-06-29 1978-06-29 Antitumor agent and its preparation

Publications (1)

Publication Number Publication Date
CS235079B2 true CS235079B2 (en) 1985-04-16

Family

ID=13650677

Family Applications (1)

Application Number Title Priority Date Filing Date
CS794488A CS235079B2 (en) 1978-06-29 1979-06-28 Method of antitumour substance preparation

Country Status (10)

Country Link
US (1) US4242326A (ja)
JP (1) JPS557014A (ja)
CA (1) CA1135640A (ja)
CH (1) CH641354A5 (ja)
CS (1) CS235079B2 (ja)
DE (1) DE2926406A1 (ja)
FR (1) FR2429594A1 (ja)
GB (1) GB2025768B (ja)
IT (1) IT1119922B (ja)
SE (1) SE449439B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4479935A (en) * 1980-04-22 1984-10-30 Institut Pasteur Fractions extracted from aerobic bacteria, endowed with antitumoral, antibacterial and interferon inducing properties, and process for their preparation
JPS58222026A (ja) * 1982-06-18 1983-12-23 Masahiro Yoshimura 抗ガン性物質
JPS6169725A (ja) * 1984-09-13 1986-04-10 Juzo Udaka 抗腫瘍性物質ｓｐｆ−１４０及びその製法
US4978622A (en) * 1986-06-23 1990-12-18 Regents Of The University Of California Cytophaga-derived immunopotentiator
US5010062A (en) * 1989-09-25 1991-04-23 Vanderbilt University Therapeutic agent and method of inhibiting vascularization of tumors
ES2027518A6 (es) * 1990-12-18 1992-06-01 Andromaco Lab Procedimiento para la preparacion de nuevas asociaciones no covalentes polisacarido-proteina con actividad farmacologica.
US5811403A (en) * 1996-09-30 1998-09-22 Vanderbilt University Polysaccharide toxin from Group B β-hemolytic Streptococcus (GBS) having improved purity
JPH10139670A (ja) * 1996-11-11 1998-05-26 Terukuni Yakida インターロイキン１２誘導物質及び医薬組成物
US5981508A (en) 1997-01-29 1999-11-09 Vanderbilt University Facilitation of repair of neural injury with CM101/GBS toxin
US6028060A (en) 1997-01-29 2000-02-22 Vanderbilt University Treatment of chronic inflammatory diseases with CM101/GBS toxin
US6670337B1 (en) * 1998-01-29 2003-12-30 Yeda Reaearch And Development Co., Ltd. Facilitation of wound healing with CM101/GBS toxin
US5858991A (en) 1997-01-29 1999-01-12 Vanderbilt University Facilitation of wound healing with CM101/GBS toxin
US8609614B2 (en) * 1998-07-22 2013-12-17 Vanderbilt University GBS toxin receptor compositions and methods of use
US6803448B1 (en) * 1998-07-22 2004-10-12 Vanderbilt University GBS toxin receptor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1132676A (en) * 1966-03-08 1968-11-06 Chugai Pharmaceutical Co Ltd Anti-tumour preparation and process for preparing the same
GB1153113A (en) 1967-01-20 1969-05-21 Chugai Pharmaceutical Co Ltd Method of Treating Hemolytic Streptococci and the Resultant Preparation containing the same
GB1163865A (en) * 1967-02-01 1969-09-10 Kyowa Hakko Kogyo Kk Process for the preparation of Anti-Tumor Substances
US3632746A (en) * 1967-08-30 1972-01-04 Chugai Pharmaceutical Co Ltd Dried stable anti-tumor preparations and process for preparing the same
JPS4843841B1 (ja) * 1969-09-06 1973-12-21
JPS496096B1 (ja) * 1970-09-30 1974-02-12
SE7505350L (sv) * 1974-05-08 1975-11-10 Wellcome Found Forfarande for framstellning av en immunostimulerande glykopeptid.

Also Published As

Publication number Publication date
FR2429594B1 (ja) 1983-04-01
FR2429594A1 (fr) 1980-01-25
US4242326A (en) 1980-12-30
SE7905703L (sv) 1979-12-30
JPS6169B2 (ja) 1986-01-06
JPS557014A (en) 1980-01-18
CA1135640A (en) 1982-11-16
GB2025768A (en) 1980-01-30
IT1119922B (it) 1986-03-19
SE449439B (sv) 1987-05-04
DE2926406A1 (de) 1980-01-10
GB2025768B (en) 1982-11-24
CH641354A5 (de) 1984-02-29
IT7968342A0 (it) 1979-06-22

Similar Documents

Publication Publication Date Title
CA1217136A (en) Refined detoxified endotoxin product
Smith et al. New histone kinases in nuclei of rat tissues
CS235079B2 (en) Method of antitumour substance preparation
Fukushi et al. Extraction and purification of endotoxin from Enterobacteriaceae: a comparison of selected methods and sources
WO2021135544A1 (zh) 一种普洱茶树叶片内生芽孢杆菌及其应用
Heckly et al. Toxins of Pseudomonas pseudomallei II: Characterization
US4812441A (en) Hypocholesterolemically active protein derived from streptococcus
CA1277617C (en) Antibiotic polypeptide, process for preparing it and the use thereof
US4645667A (en) Antitumor agent and process for manufacturing said agent
US11926853B2 (en) Botulinum toxin producing method
US6136789A (en) Polysaccharide toxin from group B -62 hemolytic streptococcus (GBS) having improved purity
Huff Lipoteichoic acid, a major amphiphile of Gram-positive bacteria that is not readily extractable
US4209507A (en) Novel anti-tumor substance and preparation thereof
US4900724A (en) Tumor necrosis factor inducing substance derived from acid-fast bacteria
US4656037A (en) SPF-100 and process for the preparation thereof
CA1100876A (en) Use of a nitrogen-containing polysaccharide for promoting drug-sensitivity of bacteria resistant to antibiotics
JPH04300898A (ja) 新規糖タンパク複合体およびその製造方法
Nerkar et al. Stimulation of macrophages and antitumor activity of radiodetoxified endotoxin
KR860001213B1 (ko) 제암 및 면역자극 작용을 갖는 물질의 제조방법
KR890002256B1 (ko) 항암 물질 tf-2 제조 방법
KR820001848B1 (ko) 항종양성(抗腫瘍性) 물질의 제조법
FR2536280A1 (fr) Composition pharmaceutique et procede pour le traitement de tumeurs
EP0186482A2 (en) Hypocholesterolemically active RNA fractions
KR900002671B1 (ko) 종양면역 증강효과가 있는 단백다당체(리오필란 a)
IKEKAWA et al. Canacelunin, a cancer cell agglutinin from Streptomyces sp.